The kilogram after the breakthrough.

A promising material still has to become something a developer can accept.

I want the commercial reasoning around Bio’s programmes to start early enough to influence the research. That does not mean pretending to know a future selling price or writing a revenue forecast around an unverified yield. It means asking what output a prospective customer would actually accept and what would have to happen to deliver it.

A kilogram of recovered material, a kilogram meeting a specification and a kilogram incorporated into an acceptable formulation need not answer the same business question. The denominator should be explicit. Otherwise a large production number can conceal a small amount of useful output.

A material-flow view is one way to examine a process.

ACS’s green-chemistry framework treats prevention and efficient resource use as design considerations (American Chemical Society, n.d.-b). I want those considerations alongside questions about energy, hazards, sourcing and the function delivered. Lower mass input alone would not establish a complete environmental advantage.

The same discipline helps commercially. A process could reduce one input while introducing a more expensive step. Another could improve recovery but create a difficult quality problem. The useful analysis makes those tensions visible so that a team can decide which trade-off deserves further work.

(American Chemical Society, n.d.)

A useful scenario reveals what changes the decision.

For an early programme, I prefer an interactive view with editable assumed inputs over an authoritative-looking valuation chart. The reader could vary accepted yield, material inputs or a stated processing-cost assumption and see which change matters most. The example must remain labelled as a scenario, with blank inputs available for a different brief.

The tool should also show what it cannot infer. It cannot discover a market price, customer demand or manufacturing capacity from its own sliders. Its job is to help a team identify the assumption that deserves evidence before a larger commitment.

A process conversation should meet the application it is intended to serve.

For a material or ingredient business, the starting point could be an acceptance criterion and a resource-intensive step. For a formulation team, it could be a performance requirement that changes what accepted output means. For an investor, it could be the evidence needed to distinguish an interesting research lead from a more investable development proposition.

I want Bio’s ambition to survive that conversation. The opportunity is not a ratio displayed in isolation. It is a material approach whose function, process and economics can be investigated together, with a clearer reason for every next step.